Nunzia Pharmaceutical Corp. (NUNZ)

Overview

Nunzia Pharmaceutical Company is engaged in the pharmaceutical and nutraceutical industry, focusing on the development and distribution of a unique product named Nunzia. The company boasts exclusive rights to manufacture, market, and distribute this nutraceutical, which is designed to address a range of disorders including autism, fragile X, ADHD, PTSD, and others. Initially established as Arizona Gold and Onyx Mining Company, it underwent a significant rebranding to Nunzia Pharmaceutical Company in February 2018. Founded in 1986 and headquartered in Long Beach, California, the company has transitioned from its original industry to make a notable impact in the pharmaceutical sector. Nunzia Pharmaceutical Company extends its product offerings through various wholesalers and directly to consumers via its dedicated website, nunziapharma.com.

Products and Services

Nunzia Pharmaceutical Company specializes in the development and distribution of Nunzia, a proprietary nutraceutical. This product represents the company's commitment to addressing a spectrum of neurological and psychological disorders through nutritional supplementation. The company's product line and services include:

• Nunzia: A nutraceutical formulated for the treatment and management of various conditions such as autism, fragile X syndrome, ADHD, and PTSD among others. By leveraging cutting-edge science in the design of its formula, Nunzia aims to provide a non-pharmacological option to support individuals dealing with these disorders. Available through the company's distribution network, Nunzia aims to reach a broad customer base in need of such specialized nutritional support.
• Distribution: Nunzia Pharmaceutical Company distributes its flagship product through a wide network of wholesalers, ensuring the nutraceutical is readily accessible across different markets. Additionally, the company offers direct sales to customers through its official website, nunziapharma.com, enabling convenient access to the product for individuals seeking alternative treatment options. This dual-channel distribution strategy is aimed at maximizing the product's reach and availability to those in need.